Indoco Remedies Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 1,39,829 shares,. Its Average Traded Price (ATP) is ₹239.31, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 35 @ ₹236.90.
Indoco Remedies has an upper circuit limit of ₹295.85 and a lower circuit limit of ₹197.25. The total value traded stands at ₹3.35 CR, and the delivery percentage for the day is 42.79%.
The stock is currently traded with a market lot size of 1. Indoco Remedies also offers a dividend yield of 0.08%.
Indoco Remedies Share Price Chart
Indoco Remedies Share Key Metrics
Volume
1.40 L
Market Cap
2275.75 CR
LTQ@LTP
35@236.90
ATP
239.31
Var Margin
24.18 %
Circuit Range
197.25-295.85
Delivery %
42.79 %
Value
3.35 CR
ASM/GSM
No
Market Lot
1
Indoco Remedies Resistance and Support
Pivot 246.87
Resistance
First Resistance
249.14
Second Resistance
251.72
Third Resistance
253.99
Support
First Support
244.29
Second Support
242.02
Third Support
239.44
Indoco Remedies Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Indoco Remedies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-07-28 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-03 | Quarterly Results |
| 2025-11-06 | Quarterly Results |
| 2025-07-24 | Quarterly Results |
| 2025-05-22 | Audited Results & Final Dividend |
| 2025-01-21 | Quarterly Results |
| 2024-10-24 | Quarterly Results |
| 2023-07-25 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-09-10 | 2026-09-10 | View More |
Indoco Remedies News
Indoco Remedies Ltd - 532612 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - ESG Rating
Indoco Remedies announced it received an unsolicited 'Crisil ESG 60' rating from Crisil ESG Ratings & Analytics. The rating was independently prepared using publicly available information.
Sep 24 2026 12:50:45
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Acquisition
Indoco Remedies has incorporated "Warren Lifesciences Private Limited" as a new wholly-owned subsidiary. This new entity will operate in the pharmaceutical sector, focusing on manufacturing, developing, and selling pharmaceutical products including APIs and finished formulations.
Sep 18 2026 17:56:44
Indoco Remedies Ltd - 532612 - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations,2015
Indoco Remedies' Goa manufacturing facility (Plant I) underwent a UK MHRA inspection from September 7-9, 2026. The inspection concluded with no critical or major observations, validating the company's quality systems for regulated markets.
Sep 10 2026 12:38:49
Indoco Remedies Management
| Name | Position |
|---|---|
| Suresh G Kare | Chairman |
| Aditi Panandikar | Managing Director |
Indoco Remedies Similar Stocks
Dishman Carbogen Amcis Ltd.
146.66
-5.80 (3.80%)
Venus Remedies Ltd.
1681.00
-88.40 (5.00%)
Sakar Healthcare Ltd.
1002.40
-17.70 (1.74%)
Sai Parenteral's Ltd.
500.45
-21.20 (4.06%)
Panacea Biotec Ltd.
344.50
-13.10 (3.66%)
Beta Drugs Ltd.
1898.00
-93.40 (4.69%)
Syncom Formulations (India) Ltd.
23.57
-1.37 (5.49%)
Windlas Biotech Ltd.
991.60
-30.40 (2.97%)
NGL Fine-Chem Ltd.
2998.90
-135.30 (4.32%)
Indoco Remedies FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in INDOCO
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC